The risks of “fast-tracking” for NTGs

The European Union is preparing to overhaul the regulations governing new genomic techniques (NGTs), with the stated aim of reconciling innovation, competitiveness, and protection. The future regulation introduces a distinction between NTG-1 and NTG-2, with differentiated assessment procedures.

However, a discreet provision raises a key question: the possibility of accelerating risk assessments for certain NTG-2 plants in the name of “sustainability.”
Yet this concept remains vague, lacking clearly defined scientific criteria.
A poorly regulated fast-track approach risks undermining the credibility of expertise and public trust.

The report argues for precise indicators, independent assessment, and post-authorization monitoring to avoid unintended negative consequences.